Pharmaceutical News

Lundbeck to Share New Migraine Research at Upcoming Medical Conference in Geneva

/ July 1, 2026

The pharmaceutical company Lundbeck will present new findings about migraine treatments at the European Academy of Neurology Congress 2026, held […]

/ June 30, 2026

The European Directorate for the Quality of Medicines & HealthCare (EDQM) has updated twenty guidelines to phase out the use

/ June 29, 2026

MSD, a pharmaceutical company, has welcomed a new recommendation from the National Institute for Health and Care Excellence (NICE) in

/ June 28, 2026

The European Commission has approved a new treatment option for adults with a specific type of advanced colon cancer that

/ June 27, 2026

Agomab Therapeutics has designed a new Phase 2b clinical trial called NOV-ERA to test its experimental drug, ontunisertib, for treating

/ June 26, 2026

A new clinical trial has started to test a potential treatment for a common type of lung cancer. Racura Oncology

/ June 24, 2026

The National Institute for Health and Care Excellence (NICE) has approved a new combination treatment for adults with untreated multiple

/ June 23, 2026

Sandoz, a major pharmaceutical company, has opened its first of three major new facilities in Slovenia by launching a $99

/ June 22, 2026

Recipharm, a company that helps other drug companies manufacture their medicines, is investing millions of dollars to expand its operations

/ June 21, 2026

Hello! I’m a pharmacist, and I want to explain GlobalData’s privacy policy in a way that’s easy to understand. This